Enanta Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 145
- Market Cap
- $275.6M
- Introduction
Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also con...
Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia
Phase 2
- Conditions
- First Posted Date
- 2005-12-28
- Last Posted Date
- 2006-09-19
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 250
- Registration Number
- NCT00270517
- Locations
- 🇺🇸
Enanta Pharmaceuticals, Inc., Watertown, Massachusetts, United States
© Copyright 2024. All Rights Reserved by MedPath